Lataa...

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers

Clear cell carcinoma and endometrioid adenocarcinoma are histologic subtypes of ovarian and uterine cancer that demonstrate unique clinical behavior but share common underlying genomic aberrations and oncogenic pathways. ARID1A mutations are more frequently identified in these tumors, in comparison...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Gynecol Oncol Res Pract
Päätekijät: Alldredge, Jill K., Eskander, Ramez N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663065/
https://ncbi.nlm.nih.gov/pubmed/29093822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-017-0052-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!